Search

Search results

262 results found

Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Parikh, Rushi, V, Annika Hebbe, Anna E Barón, Gary K Grunwald, Mary E Plomondon, Jonathan Gordin, Robert W Yeh, et al. 2023. “Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.”. Journal of the American Heart Association 12 (4): e028082.

Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.

Aggarwal, Rahul, Christian T Ruff, Saverio Virdone, Sylvie Perreault, Ajay K Kakkar, Michael G Palazzolo, Marc Dorais, et al. 2023. “Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.”. Circulation.

Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials).

Secemsky, Eric A, Alexis Matteau, Robert W Yeh, Philippe Gabriel Steg, Edoardo Camenzind, William Wijns, Eugene McFadden, Laura Mauri, and PROTECT Trial Investigators. 2015. “Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials).”. The American Journal of Cardiology 115 (12): 1678-84.

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.

Secemsky, Eric A, Robert W Yeh, Dean J Kereiakes, Donald E Cutlip, Gabriel Steg, Joseph M Massaro, Patricia K Apruzzese, Laura Mauri, and Dual Antiplatelet Therapy Study Investigators. 2017. “Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.”. JACC. Cardiovascular Interventions 10 (9): 942-54.